Table 3.

A comparison of the patient oriented outcomes between the lean controls and obese patients with and without neuropathy

Variable	Lean Without Neuropathy	Obese without neuropathy	P value*	Obese with neuropathy	P value**
Total QOL	1.4 (0.4)	1.9 (1.3)	<0.01	3.4 (2.7)	0.02
Pain QOL	1.3 (0.5)	1.9 (1.2)	<0.01	3.5 (2.3)	<0.01
Reduced sensation QOL	1.0 (0.1)	1.4 (0.9)	<0.01	4.0 (4.0)	<0.01
Sensory motor QOL	1.5 (1.4)	1.9 (1.6)	0.13	2.7 (2.9)	0.26
ADL QOL	2.0 (1.3)	2.5 (2.6)	0.16	3.7 (3.6)	0.14
Social QOL	1.7 (0.9)	1.7 (1.4)	0.79	2.7 (2.8)	0.13
McGill Pain score	1.0 (1.9)	2.8 (3.3)	<0.01	8.2 (8.6)	<0.01
VAS	6.0 (13.3)	14.8 (20.1)	<0.01	27.2 (26.9)	0.02
PPI score N, (%)			0.07		0.47
Discomforting	0 (0%)	4 (5.1%)		3 (13.0%)
Mild	5 (10%)	13 (16.5%)		3 (13.0%)
No Pain	45 (90%)	61 (77.2%)		17 (73.9%)

^*comparison is between lean controls and obese participants without neuropathy

^**comparison is between obese participants with and without neuropathy

QOL= quality of life, ADL=activities of daily living, VAS=visual analogue scale, PPI=present pain intensity